Interestingly, inflammatory bowel diseases, which show a significant association with psoriasis vulgaris, and where IL-17 cytokines play a major pathogenic role, do not respond to anti-IL-17 treatment, while psoriasis does. Here, IL17A is linked to psoriasis.